Kiniksa
1 known investors
Kiniksa is a global biopharmaceutical company that discovers and develops novel therapies for patients with unmet medical needs, with a focus on cardiovascular diseases and related conditions. The company has an FDA-approved therapy and multiple clinical-stage assets in its pipeline.
BiotechMedical Devices
Investors · 1
In the news
- Precision Wealth Strategies LLC Buys Shares of 14,063 Kiniksa Pharmaceuticals International, plc $KNSA - Markets Dailythemarketsdaily.com · 2026
- Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 4.7% -- What GF Score of 50 Tells Investorsgurufocus.com · 2026
- Here's Why You Should Add Kiniksa Stock to Your Portfolio Nowfinance.yahoo.com · 2026
- Kiniksa's ARCALYST Sales Soar 56%, Funding a Next-Gen Heart Drug Pipeline - BriefGlance.combriefglance.com · 2026